ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oklahoma » Neurological Surgery

Top Neurological Surgery Prescribers in Oklahoma

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KEVIN KLOS MD

Neurological Surgery

3,811

$895K

352
298 are 65+

0%
patients receiving schedule two controlled substances

Avg: 27%

0%
patients receiving schedule three controlled substances

Avg: 41%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

19%
prescriptions for brand name drugs

Avg: 9%

$235
Average prescription price

Avg: $177

RANDALL WEBB MD

Neurological Surgery

2,786

$1.75M

261
139 are 65+

9%
patients receiving schedule two controlled substances

Avg: 27%

7%
patients receiving schedule three controlled substances

Avg: 41%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

36%
prescriptions for brand name drugs

Avg: 9%

$627
Average prescription price

Avg: $177

STEPHEN OFORI-KWAKYE MD

Neurological Surgery

2,300

$205K

161
51 are 65+

45%
patients receiving schedule two controlled substances

Avg: 27%

65%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

15%
prescriptions for brand name drugs

Avg: 9%

$89
Average prescription price

Avg: $177

JAMES DEAN MD

Neurological Surgery

2,200

$577K

250
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 27%

0%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

41%
prescriptions for brand name drugs

Avg: 9%

$262
Average prescription price

Avg: $177

L. SIMMONS DO

Neurological Surgery

1,269

$434K

171
118 are 65+

0%
patients receiving schedule two controlled substances

Avg: 27%

0%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

33%
prescriptions for brand name drugs

Avg: 9%

$342
Average prescription price

Avg: $177

RONALD WOOSLEY M.D.

Neurological Surgery

934

$45.7K

93
54 are 65+

15%
patients receiving schedule two controlled substances

Avg: 27%

53%
patients receiving schedule three controlled substances

Avg: 41%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

9%
prescriptions for brand name drugs

Avg: 9%

$49
Average prescription price

Avg: $177

JAMES ALVIS MD

Neurological Surgery

821

$51.3K

109
49 are 65+

62%
patients receiving schedule two controlled substances

Avg: 27%

56%
patients receiving schedule three controlled substances

Avg: 41%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

1%
prescriptions for brand name drugs

Avg: 9%

$63
Average prescription price

Avg: $177

STEWART SMITH MD

Neurological Surgery

727

$46K

147
97 are 65+

31%
patients receiving schedule two controlled substances

Avg: 27%

39%
patients receiving schedule three controlled substances

Avg: 41%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

11%
prescriptions for brand name drugs

Avg: 9%

$63
Average prescription price

Avg: $177

FRANK HUX DO

Neurological Surgery

507

$28.6K

125
68 are 65+

24%
patients receiving schedule two controlled substances

Avg: 27%

30%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

9%
prescriptions for brand name drugs

Avg: 9%

$56
Average prescription price

Avg: $177

BENJAMIN BENNER MD

Neurological Surgery

505

$13.5K

159
125 are 65+

15%
patients receiving schedule two controlled substances

Avg: 27%

32%
patients receiving schedule three controlled substances

Avg: 41%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

5%
prescriptions for brand name drugs

Avg: 9%

$27
Average prescription price

Avg: $177

JOHN MAIN DO

Neurological Surgery

500

$11.9K

104
52 are 65+

17%
patients receiving schedule two controlled substances

Avg: 27%

69%
patients receiving schedule three controlled substances

Avg: 41%

16%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

0%
prescriptions for brand name drugs

Avg: 9%

$24
Average prescription price

Avg: $177

DOUGLAS KOONTZ MD

Neurological Surgery

468

$15.3K

66
30 are 65+

41%
patients receiving schedule two controlled substances

Avg: 27%

47%
patients receiving schedule three controlled substances

Avg: 41%

23%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

7%
prescriptions for brand name drugs

Avg: 9%

$33
Average prescription price

Avg: $177

BRIAN SNELL MD

Neurological Surgery

412

$11.6K

123
79 are 65+

39%
patients receiving schedule two controlled substances

Avg: 27%

37%
patients receiving schedule three controlled substances

Avg: 41%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

5%
prescriptions for brand name drugs

Avg: 9%

$28
Average prescription price

Avg: $177

DANIEL BOEDEKER MD

Neurological Surgery

411

$9,631

144
98 are 65+

14%
patients receiving schedule two controlled substances

Avg: 27%

45%
patients receiving schedule three controlled substances

Avg: 41%

16%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

4%
prescriptions for brand name drugs

Avg: 9%

$23
Average prescription price

Avg: $177

FADI NASR MD

Neurological Surgery

407

$16.3K

111
84 are 65+

41%
patients receiving schedule two controlled substances

Avg: 27%

37%
patients receiving schedule three controlled substances

Avg: 41%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

8%
prescriptions for brand name drugs

Avg: 9%

$40
Average prescription price

Avg: $177

SHON COOK MD

Neurological Surgery

406

$8,853

92
62 are 65+

79%
patients receiving schedule two controlled substances

Avg: 27%

39%
patients receiving schedule three controlled substances

Avg: 41%

17%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

4%
prescriptions for brand name drugs

Avg: 9%

$22
Average prescription price

Avg: $177

CLINTON BAIRD M.D.

Neurological Surgery

396

$13.1K

89
46 are 65+

29%
patients receiving schedule two controlled substances

Avg: 27%

44%
patients receiving schedule three controlled substances

Avg: 41%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

0%
prescriptions for brand name drugs

Avg: 9%

$33
Average prescription price

Avg: $177

QUALLS STEVENS DO

Neurological Surgery

375

$13.5K

106
63 are 65+

37%
patients receiving schedule two controlled substances

Avg: 27%

52%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

10%
prescriptions for brand name drugs

Avg: 9%

$36
Average prescription price

Avg: $177

CHARLES FULLENWIDER M.D.

Neurological Surgery

370

$7,444

124
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 27%

48%
patients receiving schedule three controlled substances

Avg: 41%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

5%
prescriptions for brand name drugs

Avg: 9%

$20
Average prescription price

Avg: $177

BARRY POLLARD MD

Neurological Surgery

368

$6,169

120
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 27%

69%
patients receiving schedule three controlled substances

Avg: 41%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

0%
prescriptions for brand name drugs

Avg: 9%

$17
Average prescription price

Avg: $177

CHRISTOPHER BARRY M.D.

Neurological Surgery

362

$12.6K

112
76 are 65+

29%
patients receiving schedule two controlled substances

Avg: 27%

43%
patients receiving schedule three controlled substances

Avg: 41%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

4%
prescriptions for brand name drugs

Avg: 9%

$35
Average prescription price

Avg: $177

JEFFREY NEES MD

Neurological Surgery

353

$10.2K

76
53 are 65+

58%
patients receiving schedule two controlled substances

Avg: 27%

36%
patients receiving schedule three controlled substances

Avg: 41%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

6%
prescriptions for brand name drugs

Avg: 9%

$29
Average prescription price

Avg: $177

JOHN MAROUK D.O.

Neurological Surgery

352

$11.2K

87
69 are 65+

39%
patients receiving schedule two controlled substances

Avg: 27%

41%
patients receiving schedule three controlled substances

Avg: 41%

18%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

4%
prescriptions for brand name drugs

Avg: 9%

$32
Average prescription price

Avg: $177

DAVID FELL MD

Neurological Surgery

329

$8,478

100
80 are 65+

50%
patients receiving schedule two controlled substances

Avg: 27%

27%
patients receiving schedule three controlled substances

Avg: 41%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

4%
prescriptions for brand name drugs

Avg: 9%

$26
Average prescription price

Avg: $177

BENJAMIN WHITE MD

Neurological Surgery

323

$10.5K

119
95 are 65+

53%
patients receiving schedule two controlled substances

Avg: 27%

21%
patients receiving schedule three controlled substances

Avg: 41%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

11%
prescriptions for brand name drugs

Avg: 9%

$33
Average prescription price

Avg: $177

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank